Episode 38 October 26, 2026 5:51 Full transcriptToxic Convertible Notes: How Death-Spiral Financing Destroys Shareholder Value
Inside Securities Law with Frederick M. Lehrer Episode Show Notes For small public companies struggling to raise capital, a convertible note can look like a financial lifeline. But when the conversion price floats with the market, that lifeline can become a trap.…
What this episode covers
Inside Securities Law with Frederick M. Lehrer Episode Show Notes For small public companies struggling to raise capital, a convertible note can look like a financial lifeline. But when the conversion price floats with the market, that lifeline can become a trap.…
- For small public companies struggling to raise capital, a convertible note can look like a financial lifeline.
- In this episode of Inside Securities Law, former SEC enforcement attorney Frederick M.
- The mechanism is straightforward but potentially destructive.
- As the stock price declines, the lender receives more shares for the same outstanding debt.
- The central issue is not simply whether a company can obtain capital, but what that capital will ultimately cost its shareholders.
Full Transcript
Toxic Convertible Notes: How Death-Spiral Financing Destroys Shareholder Value
Inside Securities Law with Frederick M. Lehrer
Episode Show Notes
For small public companies struggling to raise capital, a convertible note can look like a financial lifeline. But when the conversion price floats with the market, that lifeline can become a trap. In this episode of Inside Securities Law, former SEC enforcement attorney Frederick M. Lehrer explains variable-price convertible notes, commonly called toxic financing, and the dilution spiral that can devastate shareholders and threaten a company's survival.
The mechanism is straightforward but potentially destructive. A company borrows money through a short-term note that allows the lender to convert the debt into common stock at a discount to the market price. As the stock price declines, the lender receives more shares for the same outstanding debt. Those additional shares increase dilution, and selling pressure can contribute to further price declines, triggering another round of conversions at even lower prices. What initially appeared to be an accessible source of working capital can become a cycle of expanding share counts, declining ownership percentages, and increasingly difficult financing conditions.
Lehrer examines why companies accept these arrangements, how variable conversion formulas shift financial risk toward existing shareholders, and why directors and securities counsel must understand the potential consequences before committing to financing terms. The central issue is not simply whether a company can obtain capital, but what that capital will ultimately cost its shareholders.
For executives, directors, investors, and advisers involved with smaller public companies, this episode explains why the details of a convertible note matter long before the first conversion occurs.
About Frederick M. Lehrer
Frederick M. Lehrer is a Florida-based securities attorney and founder of Frederick M. Lehrer, P.A. He served at the U.S. Securities and Exchange Commission from 1984 to 2000, including nine years as an enforcement attorney. Since 2000, he has represented companies in securities offerings, capital raising, SEC reporting, going-public transactions, and corporate governance. His practice emphasizes accurate disclosures, regulatory compliance, and practical securities counsel informed by his experience inside the SEC.
Links and Resources
Frederick M. Lehrer, P.A.: https://securitiesattorney1.com/
Toxic Convertible Notes: How Death-Spiral Financing Destroys Shareholder Value: https://securitiesattorney1.com/blog/toxic-convertible-notes-death-spiral-financing-explained/
The Other Side of the Table — Chapter 7, Toxic Financing: https://securitiesattorney1.com/book/toxic-financing-death-spiral/
Inside Securities Law Podcast: https://fredlehrer.transistor.fm/
SEC Investor Education — Convertible Securities: https://www.investor.gov/introduction-investing/investing-basics/glossary/convertible-securities
This podcast is provided for general educational purposes and does not constitute legal or investment advice.
This transcript is published for general information only. It is not legal advice, and listening to or reading it does not create an attorney-client relationship.
Authoritative Sources
- 15 U.S.C. § 78o(a)(1) — Registration of brokers and dealers (Exchange Act § 15(a)(1)) — Cornell Legal Information Institute
- 15 U.S.C. § 78c(a)(5) — Definition of “dealer” (Exchange Act § 3(a)(5)) — Cornell Legal Information Institute
- SEC v. Keener, 102 F.4th 1328 (11th Cir. 2024) — convertible note funder as unregistered dealer — U.S. Court of Appeals for the Eleventh Circuit
- SEC Investor Guide: Microcap Stock — dilutive financing and market risks — U.S. Securities and Exchange Commission
- 17 C.F.R. § 229.303 — Item 303, Management’s Discussion and Analysis (liquidity and dilution disclosure) — Electronic Code of Federal Regulations
- 15 U.S.C. § 77c(a)(10) — Exempted securities (Securities Act § 3(a)(10)) — Cornell Legal Information Institute
Primary sources are cited so readers can verify the law directly. Rules and staff guidance change; see our editorial and corrections policy to report an error or an outdated citation.